The field of Alzheimer’s disease (AD) therapeutics is experiencing a renaissance of innovation, with 2025 marking a pivotal year in the fight against this devastating neurodegenerative condition. Researchers and clinicians worldwide are making significant strides in developing interventions that target the disease’s complex underlying mechanisms. Transformative Research Unveiled at Global Neuroscience Forum The prestigious AD/PD… Read.